The Spanish Society of Medical Oncology: objectives, structure and history

Size: px
Start display at page:

Download "The Spanish Society of Medical Oncology: objectives, structure and history"

Transcription

1 The Spanish Society of Medical Oncology: objectives, structure and history The Spanish Society of Medical Oncology (SEOM) brings together Spanish specialists who are dedicated solely to fighting cancer on all fronts: - Primary prevention (not smoking, avoiding obesity, taking physical exercise, eating fruit and vegetables) - Early diagnosis (mammograms, etc.) - Improved diagnosis (better techniques, molecular biology, PET, etc.) - Promoting a multidisciplinary approach to provide comprehensive care for cancer patients throughout the whole course of their illness - Encouraging uniformity of criteria for the treatment of cancer in its various locations and extensions. - Instigating improvements in the treatment of cancer. - Promoting research and Continued Training in order to integrate advancements and to continuously update knowledge. - Lending continuous support for any needs the patients and their families may have. SEOM is the leading organisation for Oncology in Spain and ensures that excellent-quality care is provided by the Medical Oncology Units, by encouraging the study and research of cancer. SEOM is a society which is actively dedicated to informing and educating the various groups with respect to Oncology: the medical sector, health administration, patients, families, the general public, the pharmaceutical industry and the media. Its objectives include promoting the study and research of neoplastic disease and seeking to standardise clinical/therapeutic criteria in its diagnosis and treatment. To this end, SEOM aims, on the one hand, to instigate improvements in the treatment of cancer from a care, research and educational perspective. On the other hand, to promote the multidisciplinary approach in order to provide cancer patients with comprehensive care and to encourage uniformity of criteria for the treatment of cancer in its various locations and extensions. Another of the set objectives is to establish synergy between the activities of the other groups concerned, which include patient associations, scientific societies, although they may not be related specifically to the field of oncology, such as general or family medicine, research centres and international oncology societies. 1 / 5

2 With regard to the health education of Spanish society on the subject of cancer, SEOM is actively involved in the prevention of this illness, through the promotion of health awareness initiatives aimed at the general public and projects in support of cancer patients. SEOM considers it essential to emphasise the importance of the primary prevention of cancer, early diagnosis and the role of the Genetic Advice Units where help can be given to families who are susceptible to cancer. Furthermore, SEOM contributes towards educating, informing and supporting cancer patients and their families. SEOM is committed to those suffering from cancer during all phases of their illness, also after the medical treatment has finished. SEOM promotes the importance of excellent care for cancer patients. Continued education activities are supported and carried out, both in terms of public and private entities, to ensure that medical oncologists are kept up to date with the latest therapeutic developments. In addition, it supports the production of clinical guides for the diagnosis and treatment of the most common tumours. With regard to clinical research, SEOM considers it essential to promote this area, ensuring that the time required by administration to authorise clinical trials is competitive. We have top professionals who form Cooperative Research Groups for the various types of cancer: TTD (digestive tract), GEICAM (breast), GECP (lung), etc. These Groups constitute a highly useful and valuable tool for clinical and applied cancer research. They are recognised internationally and are used to collaborate on national and international training and research projects. At SEOM we are striving to promote research in hospitals and to bring basic research closer to clinical research, providing them with more structural and economic resources and demanding official status and recognition from the Health Authorities. All of this is aimed at achieving excellent progress in translational research. The work carried out by medical oncologists in Spain has enabled us to reach the highest level in terms of science and care, which is respected by the rest of the world of oncology. This 2 / 5

3 results in an increase in cure rates and life expectancy for most cancers which have received a coordinated treatment thanks to the comprehensive role the medical oncologist plays in the strategy applied to the disease. Furthermore, at SEOM we have encouraged the relationship between the Medical Oncology Units and the Basic Research Institutions, within or outside of the thematic networks of cooperative research, in order to obtain greater synergy in translational research. Structure SEOM has an internal structure which manages and organises the activities of the Society. We have a Manager, who is responsible for the smooth running of SEOM; a Conventions Department which organises the scientific meetings we hold; a Communications Department responsible for press relations and promoting institutional and public relations activities which help to enhance the public image of SEOM; a technical secretariat and a scientific secretariat, the latter consisting of medical oncologists, members of SEOM. With this structure, SEOM is a scientific society which is strengthening its position day by day as a benchmark scientifically qualified in the field of oncology to which central and regional Health Authorities, other scientific societies, the media and the general public can refer. All this is the fruit of the efforts invested by the whole team and by the 850 members who with their work make it possible for SEOM to be one of the most active scientific societies. SEOM increases its membership daily. In September 2006 we have 850 specialists, most of whom are medical oncologists, but there are also a large number of radiotherapists, as well as geneticists and psycho-oncologists. SEOM strives on a daily basis to improve the services it provides to its members and to offer new services with the desire to facilitate the development of their professional practice. The main services offered by the Society are listed below: - Free legal advice - Professional training service - Updating and publication of the SEOM Directory - Production and delivery of newsletters (SEOM Newsletter) 3 / 5

4 - Production and distribution of activities report - Production and distribution of manuals, clinical guides and consensus documents - Website ( ) - Free delivery of the journal Seminars in Oncology in Spanish - Free access to several scientific journals of national and international importance - Advice on organising events and on communication and protocol. History and background Over the 36 years in which SEOM has been in existence, each of its presidents has worked towards improving the Society on a day-to-day basis until it has become one of the most active and high-profile scientific societies, both nationally and internationally. In 1970, the first Spanish scientific society relating to cancer was established. It was the Spanish Society of Oncology (SEO); a multidisciplinary society which brought together doctors from all specialities and also those with no speciality (pathologists, radiotherapists, surgeons, internists, etc.). In 1976, the Spanish Society of Chemotherapy (SEQUIO) was founded and as of 1981, with the speciality of Medical Oncology then officially recognised, it changed its name to the Spanish Society of Medical Oncology (SEOM). This aimed to bring together all doctors interested in the medical treatment of cancer. Medical Oncology did not exist as a speciality at that point in Spain. Its definition had been formed in 1972 in the United States and this speciality model was used as a reference in an attempt to create a branch of Medical Oncology within the SEO. However, this initiative was not very well received by other specialities, as the concept of Clinical Oncology, as it was then called, was very vague, being a multidisciplinary speciality which advocated that therapeutic decisions be taken through the clinical oncologist in a merely coordinating role. It was from there that the SEQUIO was established, which from the outset, and particularly following the publication in 1978 of the decree of specialities, fought for the creation and recognition of the speciality of Medical Oncology and not Clinical Oncology. 4 / 5

5 Spain was the first European country to establish the speciality of Medical Oncology and this step set an example for the rest of Europe. When the European Society for Medical Oncology (ESMO) was founded, Spain was the only country in which the speciality existed as such. ESMO then put pressure on the governments in other countries to establish the speciality, which now exists in the following European countries: Austria, Bosnia-Herzegovina, Croatia, Cyprus, the Czech Republic, France, Georgia, Germany, Greece, Holland, Hungary, Iceland, Italy, Poland, Portugal, Romania, Slovakia, Slovenia, Sweden, Switzerland and the United Kingdom. 5 / 5

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 HUNGARY WCPT COUNTRY PROFILE December 2017 HUNGARY HUNGARY NUMBERS WCPT Members Practising physical therapists 727 Total number of physical therapist members in your member organisation 4,000 Total number of practising

More information

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 SWEDEN WCPT COUNTRY PROFILE December 2017 SWEDEN SWEDEN NUMBERS WCPT Members Practising physical therapists 11,043 Total number of physical therapist members in your member organisation 17,906 Total number of

More information

WCPT COUNTRY PROFILE December 2017 SERBIA

WCPT COUNTRY PROFILE December 2017 SERBIA WCPT COUNTRY PROFILE December 2017 SERBIA SERBIA NUMBERS WCPT Members Practising physical therapists 622 Total number of physical therapist members in your member organisation 3,323 Total number of practising

More information

LEBANON. WCPT COUNTRY PROFILE December 2018

LEBANON. WCPT COUNTRY PROFILE December 2018 LEBANON WCPT COUNTRY PROFILE December 2018 LEBANON NUMBERS 1600 1400 1200 1000 800 600 400 200 0 Physical therapists in the country Members in MO 1,480 1,480 Total PTs in country 800000 700000 600000 500000

More information

Where we stand in EFORT

Where we stand in EFORT Where we stand in EFORT Engaging with the new EU regulatory landscape for medical devices. Challenges & opportunities Brussel, Belgium April 6, 2018 Per Kjaersgaard-Andersen Associate Professor Section

More information

DENMARK. WCPT COUNTRY PROFILE December 2018

DENMARK. WCPT COUNTRY PROFILE December 2018 DENMARK WCPT COUNTRY PROFILE December 2018 DENMARK NUMBERS 14000 12000 10000 8000 6000 4000 2000 0 Physical therapists in the country Members in MO 11,720 12,975 Total PTs in country 800000 700000 600000

More information

GERMANY. WCPT COUNTRY PROFILE December 2018

GERMANY. WCPT COUNTRY PROFILE December 2018 GERMANY WCPT COUNTRY PROFILE December 2018 GERMANY NUMBERS 160000 140000 120000 100000 80000 60000 40000 20000 0 Physical therapists in the country Members in MO 21,502 136,000 Total PTs in country 800000

More information

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal Public Health Public health is the science and art of preventing disease, prolonging

More information

European Collaboration on Dementia. Luxembourg, 13 December 2006

European Collaboration on Dementia. Luxembourg, 13 December 2006 European Collaboration on Dementia Luxembourg, 13 December 2006 2005 Call for projects Special attention has also to be given to information and definition of indicators on neurodegenerative, neurodevelopment,

More information

Smokefree Policies in Europe: Are we there yet?

Smokefree Policies in Europe: Are we there yet? Smokefree Policies in Europe: Are we there yet? 14 April 2015, 9:00 10:30am Rue de l Industrie 24, 1040 Brussels Permanent Partners: Temporary Partners: The research for the SFP Smokefree Map was partially

More information

European status report on alcohol and health Leadership, awareness and commitment

European status report on alcohol and health Leadership, awareness and commitment European status report on alcohol and health 2014 Leadership, awareness and commitment Leadership, awareness and commitment Background Strong leadership from national and local governments is essential

More information

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe 21st Congress of the European Association of Dental Public Health 1 October 2016 Budapest

More information

Alcohol-related harm in Europe and the WHO policy response

Alcohol-related harm in Europe and the WHO policy response Alcohol-related harm in Europe and the WHO policy response Lars Moller Programme Manager World Health Organization Regional Office for Europe Date of presentation NCD global monitoring framework: alcohol-related

More information

The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert

The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert Albania. Algeria. Armenia. Austria. Belarus. Belgium. Bosnia & Herzegovina. Bulgaria. Croatia. Cyprus. Czech Republic Denmark. Egypt. Estonia. Finland. Former Yugoslav Republic of Macedonia. France. Georgia.

More information

Overall survival: 1 st line therapy

Overall survival: 1 st line therapy 1 3 Overall survival: 1 st line therapy 2-year OS phase III studies mm Prices per month of oncology medicin Bloomberg Business weekly 26 Feb 2015 Presented By Veena Shankaran at 2016 ASCO Annual Meeting

More information

Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods Annual Epidemiological Report for 2015 Trichinellosis Key facts In 2015, a total of 156 confirmed cases of trichinellosis was reported from 29 EU/EEA countries. The overall notification rate was 0.03 cases

More information

Q1 What age are you?

Q1 What age are you? Q1 What age are you? Answered: 504 Skipped: 0 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 4.56% 23 3.77% 19 4.56% 23 6.15% 31 3.97% 20 6.55% 33 5.95% 30 6.75% 34 6.35% 32 4.37% 22 6.75% 34 5.56%

More information

European Status report on Alcohol and Health

European Status report on Alcohol and Health European Status report on Alcohol and Health Dr Lars Moller Regional Advisor a.i. WHO Regional Office for Europe Main killers in the WHO European Region Source: Preventing chronic diseases. A vital investment.

More information

Research paper: Legal treatment of the use of cannabis for medical purposes in the member states of the European Union

Research paper: Legal treatment of the use of cannabis for medical purposes in the member states of the European Union Parliament of Montenegro Parliamentary Institute Research Centre Research paper: Legal treatment of the use of cannabis for medical purposes in the member states of the European Union Podgorica, December

More information

Department of Biological Standardisation OMCL Network & Healthcare (DBO)

Department of Biological Standardisation OMCL Network & Healthcare (DBO) Department of Biological Standardisation OMCL Network & Healthcare (DBO) Implementation of Pathogen Reduction Technologies for Blood Components for Transfusion: Updated Table 2009-2010 COUNCIL OF EUROPE

More information

Alcohol Prevention Day

Alcohol Prevention Day Alcohol Prevention Day Rome, 16 May 2018 Hana Horka Policy Officer, Unit C4 Health Determinants and International Relations European Commission DG Health and Food Safety (SANTE) Alcohol consumption in

More information

Table 6.1 Summary information for colorectal cancer in Ireland,

Table 6.1 Summary information for colorectal cancer in Ireland, 6 Colorectal cancer 6.1 Summary Colorectal cancer is the second most common cancer in Ireland (excluding non-melanoma skin cancer). It accounts for 12% of all malignant neoplasia in females and 15% in

More information

The health economic landscape of cancer in Europe

The health economic landscape of cancer in Europe 1 Approval number The health economic landscape of cancer in Europe Bengt Jönsson, Professor Emeritus of Health Economics Stockholm School of Economics 2 Disclaimer This presentation was developed by Professor

More information

Palliative nursing care of children and young people across Europe

Palliative nursing care of children and young people across Europe Palliative nursing care of children and young people across Europe Results of a postal survey in August 2016 Updated in April 2017 (presented at the 29th PNAE-meeting in Naples/Italy on 28th April 2017)

More information

European Community Pharmacy: a reference in Public Health

European Community Pharmacy: a reference in Public Health European Community Pharmacy: a reference in Public Health Ilaria Passarani PGEU Secretary General 4 October 2018, Burgos, Spain Pharmaceutical Group of European Union Members: Professional Bodies & Pharmacists

More information

Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results

Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results E. Scafato, C. Gandin, L. Galluzzo, S. Ghirini, S. Martire Istituto Superiore

More information

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences Media Release Embargoed 00.01 CET Monday 12 th March 2012 Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences Up to 70 percent of

More information

Europa Donna in Europe and in Slovenia

Europa Donna in Europe and in Slovenia Europa Donna in Europe and in Slovenia Mojca Sencar EUROPA DONNA, The Slovenian Breast Cancer Association LJUBLJANA, SLOVENIA ED The European Breast Cancer Founded in 1994 Affiliates national forums from

More information

Table 7.1 Summary information for lung cancer in Ireland,

Table 7.1 Summary information for lung cancer in Ireland, 7 Lung cancer 7.1 Summary Lung cancer is the third most common cancer in Ireland, accounting for 15% of cancers in men and 9% in women, if non-melanoma skin cancer is excluded (table 7.1). Each year, approximately

More information

Table 9.1 Summary information for stomach cancer in Ireland,

Table 9.1 Summary information for stomach cancer in Ireland, 9 Stomach cancer 9.1 Summary Stomach cancer ranks seventh in terms of the most common cancers in Ireland, accounting for 4.1% of all malignant neoplasia in men and 2.8% in women, when non-melanoma skin

More information

Cross Border Genetic Testing for Rare Diseases

Cross Border Genetic Testing for Rare Diseases Cross Border Genetic Testing for Rare Diseases EUCERD Joint Action WP8 Helena Kääriäinen National Institute for Health an Welfare, Helsinki, Finland Starting point Possibilities and demand for genetic

More information

The Identification of Food Safety Priorities using the Delphi Technique

The Identification of Food Safety Priorities using the Delphi Technique The Identification of Food Safety Priorities using the Delphi Technique Gene Rowe & Fergus Bolger, GRE 58th Advisory Forum Meeting, Luxembourg, 8-9 December 2015 EU RISK ASSESSMENT AGENDA (RAA) where priorities

More information

COMMITTEE OF EXPERTS ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY (CD-P-PH/PHO) PROGRAMME RESULTS

COMMITTEE OF EXPERTS ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY (CD-P-PH/PHO) PROGRAMME RESULTS COMMITTEE OF EXPERTS ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY (CD-P-PH/PHO) PROGRAMME RESULTS 2016-2017 Introduction This summary provides an overview of the activities carried out by

More information

Project Meeting Prague

Project Meeting Prague Project Meeting Prague IO1 Assessment 9.11.217 CHRISTINA PADBERG ON BEHALF OF FRANKFURT UAS Current Status Assessment matrix was fully evaluated Experts have been interviewed, Interviews were fully evaluated

More information

Reflecting on ten years of progress in the fight against AIDS, TB and malaria

Reflecting on ten years of progress in the fight against AIDS, TB and malaria Reflecting on ten years of progress in the fight against AIDS, TB and malaria Michel Kazatchkine UN Secretary General s Special Envoy on HIV/AIDS in Eastern Europe and central Asia Ten years of progress:

More information

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018 Emerging Risks Mapping of Activities in Member States 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018 BACKGROUND 67 th Advisory Forum Meeting, Utrecht, The Netherlands, 6 February

More information

European Association of Dental Public Health Prevention of Oral Cancer

European Association of Dental Public Health Prevention of Oral Cancer European Association of Dental Public Health Prevention of Oral Cancer Special Interest Working Group Thursday 14th November 2013 PD Dr. Katrin Hertrampf, MPH Dr. Colwyn Jones, Associate Editor Malta 2013

More information

Sign Language Act in Europe and Hungary by dr. Ádám Kósa

Sign Language Act in Europe and Hungary by dr. Ádám Kósa Sign Language Act in Europe and Hungary by dr. Ádám Kósa Member of the European Parliament co-chair of the Disability Intergroup president of the Hungarian Association of the Deaf and Hard-of- Hearing

More information

A European vision of CPD including specialisation An interim report

A European vision of CPD including specialisation An interim report A European vision of CPD including specialisation An interim report FOR INFORMATION at the General Meeting 8 10 May 2014 Copenhagen, Denmark A EUROPEAN VISION FOR CPD INCLUDING SPECIALISATION: INTERIM

More information

CALL FOR A EUROPEAN ACTION PLAN FOR MEDICAL IMAGING TO IMPROVE QUALITY OF CARE AND PATIENT SAFETY

CALL FOR A EUROPEAN ACTION PLAN FOR MEDICAL IMAGING TO IMPROVE QUALITY OF CARE AND PATIENT SAFETY CALL FOR A EUROPEAN ACTION PLAN FOR MEDICAL IMAGING TO IMPROVE QUALITY OF CARE AND PATIENT SAFETY myesr.org QUALITY & SAFETY Improving and harmonising quality and safety in medical imaging across Europe

More information

FORUM FOR AEROSPACE NDT BOARDS

FORUM FOR AEROSPACE NDT BOARDS FORUM FOR AEROSPACE NDT BOARDS An overview of the activities of the Forum for National Aerospace NDT Boards ANDTBF/04; Rev: 2010-06-08 What is a NANDTB? EASA regulations part 145 (covering NDT in maintenance)

More information

IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos. Jonathan Hughes IOSH Vice President

IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos. Jonathan Hughes IOSH Vice President IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos Jonathan Hughes IOSH Vice President About the Institution of Occupational Safety and Health (IOSH) www.iosh.co.uk

More information

Joint Programming in Neurodegenerative Disease Research (JPND)

Joint Programming in Neurodegenerative Disease Research (JPND) Joint Programming in Neurodegenerative Disease Research (JPND) Building Alliances and Collaborations Prof. Philippe Amouyel, MD, PhD JPND Chair France Disclosure CEO of Fondation Plan Alzheimer Conference

More information

EUDY JUNIOR CAMP 2018 FIRST ANNOUNCEMENT

EUDY JUNIOR CAMP 2018 FIRST ANNOUNCEMENT EUDY JUNIOR CP 2018 FIRST ANNOUNCEMENT 21. 29. July 2018 Tesáre, SLOVAKIA IDENTITY OF THE DEAF EUROPEAN UNION OF THE DEAF YOUTH (EUDY) The European Union of the Deaf Youth is a European non-profit organisation

More information

Monthly measles and rubella monitoring report

Monthly measles and rubella monitoring report SURVEILLANCE REPORT Monthly measles and rubella monitoring report December 2018 Period covered: 1 November 2017 to 31 October 2018 Introduction This monitoring report is based on measles and rubella data

More information

EFSA s Concise European food consumption database. Davide Arcella Data Collection and Exposure Unit

EFSA s Concise European food consumption database. Davide Arcella Data Collection and Exposure Unit EFSA s Concise European food consumption database Davide Arcella Data Collection and Exposure Unit 1 The EFSA raison d être Risk assessment authority created in 2002 as part of a comprehensive program

More information

Pharmacy Ownership and Establishment

Pharmacy Ownership and Establishment Pielikums Nr.2 Pharmacy Ownership and Establishment Ref: 09.07.06E 012FS Pharmacy Ownership and Establishment Ownership information on who is entitled to own a Pharmacy. Reference should be made if ownership

More information

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Biology Report Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Introduction Tuberculosis is a serious disease caused by the bacterium Mycobacterium

More information

Nutrient profiles for foods bearing claims

Nutrient profiles for foods bearing claims Nutrient profiles for foods bearing claims Fields marked with * are mandatory. Background Regulation (EC) 1924/2006 (Nutrition and Health Claims NHC Regulation) establishes EU rules on nutrition and health

More information

Underage drinking in Europe

Underage drinking in Europe Underage drinking in Europe There are two major studies on underage drinking which are published every 4 years: HBSC (Health Behaviour in School-aged Children) and ESPAD (The European School survey Project

More information

COMMISSION OF THE EUROPEAN COMMUNITIES

COMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 22.12.2008 COM(2008) 882 final REPORT FROM THE COMMISSION TO THE COUNCIL, THE EUROPEAN PARLIAMENT, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE

More information

REPORT ON LAWS AND RECOMMENDATIONS ON DENTAL MERCURY MANAGEMENT IN THE EU

REPORT ON LAWS AND RECOMMENDATIONS ON DENTAL MERCURY MANAGEMENT IN THE EU 0 REPORT ON LAWS AND RECOMMENDATIONS ON DENTAL MERCURY MANAGEMENT IN THE EU 31/01/2018 0 1 Contents 1. Introduction... 2 2. Phasing out the use of dental amalgam... 3 3. Use of encapsulated dental amalgam...

More information

The cancer burden in the European Union and the European Region: the current situation and a way forward

The cancer burden in the European Union and the European Region: the current situation and a way forward The cancer burden in the European Union and the European Region: the current situation and a way forward Presented by Zsuzsanna Jakab WHO Regional Director for Europe Informal Meeting of Health Ministers

More information

Where do EU Contries set the limit for low risk drinking.

Where do EU Contries set the limit for low risk drinking. Where do EU Contries set the limit for low risk drinking. Results from the EU RARHA survey E. Scafato,L. Galluzzo, S. Ghirini, C. Gandin Istituto Superiore di Sanità, Italy WP5: Outline of the work (tasks)

More information

Rheumatoid Arthritis Disease Burden and Access to Treatment

Rheumatoid Arthritis Disease Burden and Access to Treatment Berlin, April 2012 Rheumatoid Arthritis Disease Burden and Access to Treatment Gisela Kobelt, PhD Visiting Professor, Lund University (Sweden) President, European Health Economics (France) Disclaimers

More information

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10% % of reported measles cases WHO EpiBrief A report on the epidemiology of selected vaccine-preventable diseases in the European Region No. /17 This issue of WHO EpiBrief provides an overview of selected

More information

Prevention of Oral Cancer Special Interest Working Group

Prevention of Oral Cancer Special Interest Working Group Prevention of Oral Cancer Special Interest Working Group Dr Colwyn Jones, Consultant in Dental Public Health, NHS Health Scotland, 1 South Gyle Crescent, Edinburgh EH12 9EB, Scotland. colwyn.jones@nhs.net

More information

Impact of education: challenges and recommendations

Impact of education: challenges and recommendations Rigshospitalet Integrated Oncology and Palliative Care The Lancet Oncology Commission Impact of education: challenges and recommendations Per Sjøgren and Geana Kurita Palliative Research Group, Dept. Oncology,

More information

The Risk of Alcohol in Europe. Bridging the Gap June 2004

The Risk of Alcohol in Europe. Bridging the Gap June 2004 The Risk of Alcohol in Europe Bridging the Gap 16-19 June 2004 1. What is the relationship between alcohol and the risk of heart disease? 2. What is the relationship between alcohol and the risk of other

More information

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA September 2017 Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional Office for Europe Marmorvej

More information

EUVAC.NET A surveillance network for vaccine-preventable diseases

EUVAC.NET A surveillance network for vaccine-preventable diseases EUVAC.NET A surveillance network for vaccine-preventable diseases Mark Muscat EUVAC.NET Co-ordinator Department of Epidemiology Statens Serum Institut Denmark Email: mmc@ssi.dk Viral Hepatitis Prevention

More information

Real Life, Real PD Survey

Real Life, Real PD Survey Real Life, Real PD Survey Final Pan-European Survey Results Survey Objectives The survey was carried out to provide insights into the realities of living with PD and to highlight some of the symptoms of

More information

EFSA s activities on data collection (Art. 33) and proposal for a new initiative (EUMENU) H. Deluyker Director

EFSA s activities on data collection (Art. 33) and proposal for a new initiative (EUMENU) H. Deluyker Director EFSA s activities on data collection (Art. 33) and proposal for a new initiative (EUMENU) H. Deluyker Director Scientific Cooperation and Assistance 43 rd Management Board Meeting Stockholm, 17 December

More information

Overview of drug-induced deaths in Europe - What does the data tell us?

Overview of drug-induced deaths in Europe - What does the data tell us? Overview of drug-induced deaths in Europe - What does the data tell us? João Matias, Isabelle Giraudon, Julián Vicente EMCDDA expert group on the key-indicator Drug-related deaths and mortality among drug

More information

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE 2018 2019 WINTER SEASON October 2018 Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional Office for

More information

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS EUROPEAN COMMISSION Brussels, 17.6.011 COM(011) 35 final REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

More information

TEDDY. Teddy Network of Excellence. Annagrazia ALTAVILLA. Ph.D. Sciences Ethics LL.M. Health Law. diterranée

TEDDY. Teddy Network of Excellence. Annagrazia ALTAVILLA. Ph.D. Sciences Ethics LL.M. Health Law. diterranée Teddy Network of Excellence Annagrazia ALTAVILLA TEDDY Task-force in Europe for Drug Development for the Young Ph.D. Sciences Ethics LL.M. Health Law Associated Senior Lecturer Université de la MéditerranM

More information

Differences make a Difference

Differences make a Difference Differences make a Difference The European Mens Health Forum: Overview European Mens Health: An oxymoron? Mens use of services: Self-care & navigation Good practice: Wot does work? A Storm is coming: Man

More information

The EHRA White Book 2009 The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert

The EHRA White Book 2009 The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert Albania. Algeria. Armenia. Austria. Belarus. Belgium. Bosnia & Herzegovina. Bulgaria. Croatia. Cyprus. Czech Republic Denmark. Egypt. Estonia. Finland. Former Yugoslav Republic of Macedonia. France. Georgia.

More information

ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY

ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY JACEK MOSKALEWICZ INSTITUTE OF PSCHIATRY AND NEUROLOGY WARSAW, POLAND THIRD EUROPEAN CONFERENCE ON ALCOHOL AND LAW ENFORCEMENT,

More information

Measles and rubella monitoring January 2015

Measles and rubella monitoring January 2015 Measles and rubella monitoring January 215 Reporting on January December 214 surveillance data and epidemic intelligence data to the end of January 215 Main developments Measles During the 12-month period

More information

This document is a preview generated by EVS

This document is a preview generated by EVS EESTI STANDARD EVS-EN 14885:2006 Chemical disinfectants and antiseptics - Application of European Standards for chemical disinfectants and antiseptics Chemical disinfectants and antiseptics - Application

More information

Cost of Disorders of the Brain in Europe Gustavsson et al. Cost of disorders of the brain in Europe Eur. Neuropsych. (2011) 21,

Cost of Disorders of the Brain in Europe Gustavsson et al. Cost of disorders of the brain in Europe Eur. Neuropsych. (2011) 21, Cost of Disorders of the Brain in Europe 2010 Gustavsson et al. Cost of disorders of the brain in Europe 2010. Eur. Neuropsych. (2011) 21, 718-779 Steering Committee Prof Jes Olesen 1 Prof Bengt Jönsson

More information

11 Melanoma of the skin

11 Melanoma of the skin 11 Melanoma of the skin 11.1 Summary Melanoma of the skin is the ninth most common cancer in Ireland, accounting for 2.4 of all malignant neoplasia in men and 4.2 in women, if non-melanoma skin cancers

More information

Perspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU

Perspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU Perspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU N. Safrany European Commission Pr. A. Nicoll ECDC 2 nd WHO GAP mtg 12-14 July 2011 Background

More information

Secondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION

Secondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION Secondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION Dr Kornelia Kotseva National Heart & Lung Insitute Imperial College London, UK on behalf of all investigators participating

More information

UK bowel cancer care outcomes: A comparison with Europe

UK bowel cancer care outcomes: A comparison with Europe UK bowel cancer care outcomes: A comparison with Europe What is bowel cancer? Bowel cancer, which is also known as colorectal or colon cancer, is a cancer that affects either the colon or the rectum. The

More information

'SECTION B EU PARTY. The following abbreviations are used:

'SECTION B EU PARTY. The following abbreviations are used: 'SECTION B EU PARTY The following abbreviations are used: AT Austria BE Belgium BG Bulgaria CY Cyprus CZ Czech Republic DE Germany DK Denmark ES Spain EE Estonia EU European Union, including all its Member

More information

Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe

Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe Jürgen Rehm 1-4 Kevin D. Shield 1,2,3 1) Centre for Addiction and Mental Health, Toronto, Canada 2) University of Toronto, Canada

More information

Alcohol in Europe and Brief Intervention. Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe

Alcohol in Europe and Brief Intervention. Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe Alcohol in Europe and Brief Intervention Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe Global risk factors ranked by attributable burden of disease 2010 (GBD, Lancet,

More information

8 th Congress of ECCO

8 th Congress of ECCO European Crohn s and Colitis Organisation Vienna Austria 8 th Congress of ECCO Austria Center Vienna February 14-16, 2013 The major educational event in the field of Inflammatory Bowel Diseases in Europe

More information

Useful EU information on organ donation and transplantation

Useful EU information on organ donation and transplantation Useful EU information on organ donation and transplantation 1) EU funded and co-funded Projects European Training Program on Organ Donation - EPTOD The aim of this project is to design a professional European

More information

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information PARALLELISM AND THE LEGITIMACY GAP 1 Appendix A Country Information PARALLELISM AND THE LEGITIMACY GAP 2 Table A.1 Sample size by country 2006 2008 2010 Austria 2405 2255 0 Belgium 1798 1760 1704 Bulgaria

More information

To provide information on the new standard, a number of EOG members formed a committee to compile information on the following basis:

To provide information on the new standard, a number of EOG members formed a committee to compile information on the following basis: EN 13537 Sleeping Bag Standard Information for Retailers 30.12.2004 Disclaimer This information sheet has been provided by the EOG to help companies assess the implications of the new EN 13537 norm on

More information

31 countries (117 registries, 20 national) Increased coverage in countries with regional registries 50% European population Overall >20 million

31 countries (117 registries, 20 national) Increased coverage in countries with regional registries 50% European population Overall >20 million 31 countries (117 registries, 20 national) Increased coverage in countries with regional registries 50% European population Overall >20 million cancer cases Adult patients (age 15+) 45 major cancer sites

More information

GLP in the European Union Ecolabel detergents, GLP and accreditation

GLP in the European Union Ecolabel detergents, GLP and accreditation GLP in the European Union Ecolabel detergents, GLP and accreditation Maik Schmahl Brussels, 25/03/2010 Chemicals Unit Outline What is GLP? How has it developed? The role of the Member States, the European

More information

Clinical Evidence in the Daily Work of an Anthroposophic Hospital Dr. med. Harald Matthes, Medical Director, Havelhöhe Hospital in Berlin

Clinical Evidence in the Daily Work of an Anthroposophic Hospital Dr. med. Harald Matthes, Medical Director, Havelhöhe Hospital in Berlin Programme Venue: Time: Chair: Presentations: Members Salon, European Parliament 8:00 9:30 am Marian Harkin MEP Research Evidence in Homeopathy: Overview of published clinical investigations Robert Mathie

More information

Outcome of proficiency test on EIA serology

Outcome of proficiency test on EIA serology Outcome of proficiency test on EIA serology Anses Dozulé Laboratory for equine diseases VIPARE unit Delphine Gaudaire EIA PT GENERAL INFORMATION AIM OF THE PT Detect EIA antibodies: using Agar Gel Immuno-Diffusion

More information

La Réanimation en Europe

La Réanimation en Europe La Réanimation en Europe - la même chose partout?- Jean-Daniel Chiche, MD PhD MICU & Dept of Host-Pathogen Interaction Hôpial Cochin & Institut Cochin, Paris-F How could this be? How could this be? Always

More information

Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Introduction Tuberculosis is a serious disease caused by the bacterium Mycobacterium tuberculosis.

More information

(Adopted by the Committee of Ministers on 19 January 2011 at the 1103rd meeting of the Ministers Deputies)

(Adopted by the Committee of Ministers on 19 January 2011 at the 1103rd meeting of the Ministers Deputies) Resolution CM/ResAP(2011)1 on quality and safety assurance requirements for medicinal products prepared in pharmacies for the special needs of patients (Adopted by the Committee of Ministers on 19 January

More information

Primary and secondary prevention of sudden cardiac death in emerging economies

Primary and secondary prevention of sudden cardiac death in emerging economies Primary and secondary prevention of sudden cardiac death in emerging economies Béla Merkely MD, PhD, DSc, FESC Heart Center Semmelweis University Budapest Common risk factors for sudden cardiac death Increasing

More information

Perspectives for information on alcohol use in the EU

Perspectives for information on alcohol use in the EU EMCDDA Perspectives for information on alcohol use in the EU Julian Vicente Luxembourg 20-21 March 2018 CNAPA meeting Topics in this presentation ESPAD project (now with EMCDDA) in students Alcohol ( Tobacco

More information